The outcome of G-CSF MPB vs. BM-based allogeneic transplantation has been characterized from the clinical point of view32, with G-CSF MPB source displaying rapid recovery from neutropenia, reduced time of platelet-transfusion dependency and similar long-term reconstitution performance. The gene discussed is CSF3; the disease is Decreased total neutrophil count.